CAS 148490-22-6

4H-Pyrrolo[3,2,1-ij]quinolin-8-ol, 4-butyl-5,6-dihydro-2-methyl-1-[2-[4-(4-methyl-2-pyridinyl)-1-piperazinyl]ethyl]-

Description:

4H-Pyrrolo[3,2,1-ij]quinolin-8-ol, 4-butyl-5,6-dihydro-2-methyl-1-[2-[4-(4-methyl-2-pyridinyl)-1-piperazinyl]ethyl]- is a complex organic compound characterized by its multi-ring structure, which includes a pyrroloquinoline framework. This compound features various functional groups, including a butyl chain and a piperazine moiety, which contribute to its potential biological activity. The presence of nitrogen atoms in the structure suggests that it may exhibit properties typical of nitrogen-containing heterocycles, such as enhanced solubility and the ability to interact with biological targets. Its molecular structure indicates potential applications in medicinal chemistry, particularly in the development of pharmaceuticals targeting neurological or psychiatric conditions, given the piperazine and pyridine components, which are often associated with such therapeutic areas. Additionally, the compound's unique arrangement of substituents may influence its pharmacokinetic properties, including absorption, distribution, metabolism, and excretion (ADME). Further studies would be necessary to fully elucidate its biological activity and potential applications.

Formula: C₂₈H₃₈N₄O

Synonyms:

• 4-Butyl-5,6-dihydro-2-methyl-1-[2-[4-(4-methyl-2-pyridinyl)-1-piperazinyl]ethyl]-4H-pyrrolo[3,2,1-ij]quinolin-8-ol
• 4H-Pyrrolo[3,2,1-ij]quinolin-8-ol, 4-butyl-5,6-dihydro-2-methyl-1-[2-[4-(4-methyl-2-pyridinyl)-1-piperazinyl]ethyl]-

KC-11404

CAS: 148490-22-6

KC-11404 is an LTB4 inhibitor for the treatment of b-cell leukemias and lymphomas, potently inhibiting histamine, platelet activating factor and 5-lipoxygenase.

Formula: C₂₈H₃₈N₄O

Color and Shape: Solid

Molecular weight: 446.63

Ref: TM-T70563